focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTEG.L Regulatory News (TEG)

  • There is currently no data for TEG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Ten Entertainment Group plc

17 Jan 2024 15:30

Form 8.3 - Ten Entertainment Group plc

U.K. DISCLOSURE, Jan. 17, 2024 (GLOBE NEWSWIRE) -- FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Identity of the person whose positions/dealings are being disclosed:Glazer Capital, LLC
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficientNA
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeTen Entertainment Group plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:NA
(e) Date position held/dealing undertaken:January 16, 2024
(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 1p ordinary
 InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:    
(2) Derivatives (other than options):1,479,6372.16%  
(3) Options and agreements to purchase/sell:    
TOTAL:1,479,6372.16%  

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other executive options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a) Purchases and sales

Class of relevant securityPurchase/sale Number of securitiesPrice per unit
    
    
    

(b) Derivatives transactions (other than options)

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
1p ordinaryTotal return swapIncreasing a long position247,5004.11 GBP
     
     
     
     
     

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
        

(ii) Exercising

Class of relevant securityProduct description e.g. call optionNumber of securitiesExercise price per unit
    

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
    

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:January 17, 2024
Contact name:Ava Lederer
Telephone number:212-808-7306

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
4th Apr 20237:00 amRNSAnnual Report and AGM Notice
31st Mar 20235:49 pmRNSExecutive directors share purchase
22nd Mar 20235:35 pmRNSPerformance Share Plan Awards
22nd Mar 20237:00 amRNSFull-Year Results
13th Jan 20233:17 pmRNSDirector/PDMR Shareholding
11th Jan 20237:00 amRNSFull-Year Trading Update
5th Jan 20237:00 amRNSNotice of Full-Year Trading Update
13th Dec 20222:53 pmRNSHolding(s) in Company
18th Nov 20224:40 pmRNSSecond Price Monitoring Extn
18th Nov 20224:35 pmRNSPrice Monitoring Extension
10th Oct 20227:00 amRNSAppointment of Non-Executive Director
30th Sep 20225:46 pmRNSHolding(s) in Company
21st Sep 20227:00 amRNSHalf Year Results
8th Sep 20228:00 amRNSNotice of Half-Year Results
5th Sep 20224:35 pmRNSPrice Monitoring Extension
6th Jul 20227:00 amRNSTrading Update
23rd Jun 20227:00 amRNSNotice of Half-Year Trading Update
1st Jun 20224:20 pmRNSHolding(s) in Company
1st Jun 20224:18 pmRNSHolding(s) in Company
31st May 20227:00 amRNSTotal Voting Rights
30th May 20224:35 pmRNSPrice Monitoring Extension
24th May 20223:05 pmRNSHolding(s) in Company
18th May 20225:24 pmRNSDirector/PDMR Shareholding
12th May 20225:36 pmRNSTotal Voting Rights
4th May 20222:27 pmRNSResult of AGM
28th Apr 20223:05 pmRNSHolding(s) in Company
26th Apr 20225:06 pmRNSHolding(s) in Company
22nd Apr 20228:09 amRNSHolding(s) in Company
19th Apr 202210:09 amRNSHolding(s) in Company
11th Apr 202210:33 amRNSHolding(s) in Company
11th Apr 20227:00 amRNSExecutive directors share purchase
5th Apr 20227:00 amRNSAnnual Report and AGM Notice
30th Mar 20224:41 pmRNSPerformance Share Plan Awards
29th Mar 20227:00 amRNSFull-Year Results
15th Mar 20228:00 amRNSNotice of Results and Investor Presentation
31st Jan 202210:59 amRNSHolding(s) in Company
6th Jan 20227:00 amRNSFull Year Trading Update
21st Dec 20214:41 pmRNSSecond Price Monitoring Extn
21st Dec 20214:36 pmRNSPrice Monitoring Extension
10th Dec 20214:41 pmRNSSecond Price Monitoring Extn
10th Dec 20214:36 pmRNSPrice Monitoring Extension
6th Dec 20214:22 pmRNSDirector/PDMR Shareholding
4th Nov 20217:00 amRNSTrading Update and Outlook for 2021
26th Oct 202110:13 amRNSHolding(s) in Company
22nd Oct 20213:21 pmRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSPerformance Share Plan Awards
24th Sep 20213:44 pmRNSDirector/PDMR Shareholding
23rd Sep 20211:07 pmRNSHolding(s) in Company
22nd Sep 20217:00 amRNSHalf Year Results
8th Sep 20214:41 pmRNSNotice of Half Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.